KRAS and BRAF Mutational Status can be Accurately Determined on Diagnostic Tissue Biopsies: An Analysis of Matched Biopsy and Resection Material from Patients with Colon Cancer in the NCRI FOxTROT trial

Documenti analoghi

• Histopathological Downstaging of Colon Cancer Following Six Weeks of Pre-operative Chemotherapy: Early Results of the NCRI FOxTROT Trial
  di: West, N, et al.
  Pubblicazione: (2012)
• FOxTROT: Randomized phase II study of neoadjuvant chemotherapy with or without an anti-EGFR monoclonal antibody for locally advanced, operable colon cancer
  di: Gray, R, et al.
  Pubblicazione: (2010)
• FOxTROT: Randomized phase II study of neoadjuvant chemotherapy (CT) with or without an anti-EGFR monoclonal antibody for locally advanced, operable colon cancer: Planned interim report
  di: Morton, D, et al.
  Pubblicazione: (2011)
• Transurethral resection biopsy as part of a saturation biopsy protocol: a cohort study and review of the literature.
  di: Yates, DR, et al.
  Pubblicazione: (2013)
• Optimal timing of chemoradiation after resection or biopsy of glioblastomas: a nationwide population-based study
  di: Lee, D, et al.
  Pubblicazione: (2024)